Literature DB >> 447557

Immunotherapy in ocular equine sarcoid.

J M Murphy, G A Severin, J D Lavach, D I Hepler, D C Lueker.   

Abstract

A modified Bacillus Calmette-Guerin (BCG) preparation was used successfully in the treatment of 7 cases of equine sarcoid. The BCG preparation was injected into the lesions. The longest period of remission has been 24 months, and the shortest period of remission has been 9 months, with no signs of recurrence of the tumor in any of the presented cases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447557

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.

Authors:  W R Klein; G E Bras; W Misdorp; P A Steerenberg; W H de Jong; R H Tiesjema; A W Kersjes; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Clinico-pathological aspects of immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma.

Authors:  W Misdorp; W R Klein; E J Ruitenberg; G Hart; W H de Jong; P A Steerenberg
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

Authors:  W H de Jong; P A Steerenberg; J G Kreeftenberg; R H Tiesjema; W Kruizinga; L M van Noorle Jansen; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.